We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Benefits · 7 min read

A letter of medical necessity for HSA/FSA: what it is and when you need one

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published · Updated

Understand what an LMN documents, when an administrator may request it and why a letter never guarantees reimbursement.

A letter of medical necessity, often called an LMN, is documentation from a qualified clinician explaining a diagnosed condition and why a service or item is needed. An HSA or FSA administrator may request it when the medical purpose of an expense is not clear from the receipt or standard documentation.

An LMN is not a prescription for reimbursement. It does not guarantee that an expense qualifies or that an administrator will approve a claim.

Why might an administrator request one?

The IRS distinguishes medical care—such as diagnosis, treatment or prevention of disease—from expenses merely beneficial to general health. Some purchases have an obvious medical purpose in one situation and a general-wellness purpose in another.

A weight-management program, nutrition service, device or membership can include different components. The administrator may need documentation to understand whether a particular expense meets the applicable requirements.

A card transaction being accepted does not remove the need for substantiation. Keep the receipt and any clinical documentation even if payment went through.

What should the letter contain?

Requirements vary, so ask the administrator for its current form or checklist. A useful letter normally identifies the patient, diagnosed condition, recommended service or item, medical rationale and relevant time period. It should be signed by a clinician who can accurately support the statements.

It should not exaggerate a diagnosis, guarantee an outcome or describe care the clinician did not review. Do not edit a clinician’s letter or reuse it for an unrelated purchase.

Kindr’s public guide explains the process, but it does not automatically generate a valid LMN. Documentation must come from an appropriate clinical relationship and accurate records.

Which records belong with the letter?

Keep the itemized invoice or receipt, date, provider or merchant, amount and description of the service or product. Add a prescription when relevant and any administrator claim form.

If an employer paid part of the cost, show the employee share separately. Do not request reimbursement for an amount already paid by an employer, insurer or another account. If the program fee and medication were paid to different parties, retain both records.

Does an LMN make every GLP-1 program eligible?

No. A GLP-1 charge may include clinical visits, medication, coaching, administration and shipping. Each component can require separate review. The letter does not turn a general membership into a qualified medical expense by itself.

HSA and FSA funds may be used for qualified expenses under tax rules and the account’s requirements. The administrator decides eligibility. A clinician decides medical appropriateness. Neither decision replaces the other.

When should you ask for the letter?

Ask the administrator before paying whenever possible. Find out whether it requires a specific form, diagnosis language, annual renewal or additional receipts. Then ask your clinical team whether accurate documentation can be provided.

Do not wait until a filing deadline if the administrator needs review time. Keep copies of everything submitted and the administrator’s response.

Read the HSA and FSA eligible telehealth hub for the documentation checklist, use the letter guide for the request process, and take the coverage check if you also need to review payment options.

This article is educational and is not tax or medical advice. Your account administrator and qualified tax professional can address your situation.

Sources

Medically reviewed by Kindr Health Clinical Team
Last updated: November 15, 2026

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Research

Hormone therapy dispensing has more than doubled: what the new JAMA data mean for you

A new JAMA analysis of pharmacy dispensing, as reported by Science News, finds monthly hormone therapy dispensing to women aged 40 to 74 more than doubled since 2023, with growth in transdermal and vaginal estrogen while pills stayed flat, and we look at what that means for planning care

Research

Menopause equity: why so many women still fall through the cracks, and how to get the care you deserve

An AMWA position paper names gaps that still keep people from menopause care: training, screening, coverage, research and stigma. We look at what's changing in state law, a new academic post in British Columbia, and ACOG's guidance, and we offer a practical checklist for getting evaluated.

Research

Menopause care is going mainstream in state law: what's changing on coverage, education and work

Statehouses are moving on menopause coverage, education and work: what Illinois has enacted, what is pending in Pennsylvania, and what to ask your insurer. A federal survey also shows how few symptomatic women ages 40 to 60 currently take a prescription, and we look at how ACOG's new guidance fits in.

Explore your next step

Kindr Care is being updated, and the exact clinical process will depend on the current care pathway.

Explore care options →